A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis.

NCT07543224 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis Subjects

Interventions

DRUG: RSS0393 ointment 0.03%
DRUG: RSS0393 ointment placebo

Sponsor

Reistone Biopharma Company Limited